Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Risk Factors and Outcomes in Patients With Stable Coronary Artery Disease and Coronary Chronic Total Occlusion
1 other identifier
observational
3,000
1 country
1
Brief Summary
This study aims to assess the risk factors and evaluate the long-term outcomes of patients with coronary chronic total occlusion (CTO) treated with percutaneous coronary intervention or medical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 13, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
November 18, 2024
November 1, 2023
17 years
November 13, 2023
November 14, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
The degree of collateral estimated visually by Rentrop score during coronary angiography
The degree of coronary collateralization supplying the distal area of the total coronary occlusion was visually graded using the Rentrop scoring system as follows: 0=no visible collaterals; 1=poorly opacified collaterals with faint visualization of the distal vessel; 2=partial filling of the collateral vessels; and 3=complete filling of the collateral vessels. Patients were then classified as poor coronary collaterals (Rentrop scores of 0 and 1) or good coronary collaterals (Rentrop scores of 2 and 3), according to the Rentrop score.
Immediate post-angiography
Composite event of all-cause mortality, non-fatal myocardial infarction, heart failure and repeat revascularization
up to 5 years
Secondary Outcomes (7)
Event of all-cause mortality
up to 5 years
Event of death from cardiac causes
up to 5 years
Event of heart failure
up to 5 years
The change of left ventricular ejection fraction
1 year
Events of repeat revascularization
up to 5 years
- +2 more secondary outcomes
Other Outcomes (1)
The level of serum markers and biochemical indexes which have been reported to closely related to cardiovascular diseases and collateral formation.
up to 5 years
Study Arms (2)
Patients with good coronary collaterals
Coronary collateral circulation development was graded according to the Rentrop score, grade 2 (partial filling of the epicardial segment by collateral vessels); grade 3 (complete filling of the epicardial artery by collateral vessels) were defined as good coronary collateral circulation.
Patients with poor coronary collaterals
Coronary collateral circulation development was graded according to the Rentrop score, grade 0 (no filling of any collateral vessels) and grade 1 (filling of side branches of the artery to be perfused by collateral vessels without visualization of the epicardial segment) were defined as poor coronary collateral circulation.
Interventions
Eligibility Criteria
Patients with coronary artery disease and CTO undergone coronary angiography at Ruijin Hospital, Shanghai, China will be consecutively enrolled.
You may qualify if:
- Age ≥18 years; Patients with angina or silent ischemia and documented ischemia; Patients with CTO ≥ 3months
You may not qualify if:
- eGFR\<15mL/(min·1.73m2); Chronic heart failure with NYHA grade ≥3; Had a history of coronary artery bypass grafting; Had received a percutaneous coronary intervention within the prior 3 months; Malignant tumor or immune system disorders; Pulmonary heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Fenghua Ding, PhD, MD
Ruijin Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2023
First Posted
November 18, 2023
Study Start
January 1, 2010
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
November 18, 2024
Record last verified: 2023-11